Skip to Content
Merck
CN

719846

Resomer® X 206 S, poly(dioxanone)

Synonym(s):

PDS

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
(C4H6O3)n
CAS Number:
MDL number:
UNSPSC Code:
12162002
NACRES:
NA.23
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

SMILES string

O1CCOC(=O)C1

InChI

1S/C4H6O3/c5-4-3-6-1-2-7-4/h1-3H2

InChI key

VPVXHAANQNHFSF-UHFFFAOYSA-N

form

solid

degradation timeframe

<6 months

inherent viscosity

1.5-2.2 dL/g, 0.1 % (w/v) in hexafluoroisopropanol(30 °C, Ubbelohde) (size 0c glass capillary viscometer)

transition temp

Tg −10-−5 °C, Tm 110-115 °C

storage temp.

−20°C

Quality Level

General description

Polydioxanone (PDO) is a colorless, crystalline, highly flexible and resorbable biopolymer.

Application

PDO is widely used as a monofilament wound suture. PDO/elastin-based blends prepared by electrospinning may be used as cardiovascular grafts.

Legal Information

Product of Evonik
RESOMER is a registered trademark of Evonik Rohm GmbH

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mitchell D Eggers et al.
Journal of vascular and interventional radiology : JVIR, 23(8), 1023-1030 (2012-07-31)
To test absorbable materials as a prelude to development of an absorbable vena cava filter for the prevention of pulmonary embolism (PE). Three absorbing polymer candidates, poliglecaprone (Monocryl; sizes 4-0 and 1), polyglactin (Vicryl; sizes 4-0 and 1), and polydioxanone
O Hakimi et al.
European cells & materials, 24, 344-357 (2012-10-24)
Rotator cuff tendon pathology is thought to account for 30-70 % of all shoulder pain. For cases that have failed conservative treatment, surgical re-attachment of the tendon to the bone with a non-absorbable suture is a common option. However, the failure
Jean W M Gardeniers et al.
Clinical orthopaedics and related research, 471(7), 2225-2230 (2013-03-06)
Surgical treatment options for sternoclavicular joint luxations described in the literature are numerous, although all have limitations. Therefore, there is no favorable surgical treatment for sternoclavicular luxations when nonoperative treatment has failed. We developed the polydioxanone (PDS) envelope plasty, a
Georgette Oni et al.
Plastic and reconstructive surgery, 130(4), 535e-540e (2012-09-29)
The use of knotless barbed sutures has shortened operation times for wound closure. In experimental models, their use in tendon surgery is still under investigation. This study looks at the use of barbed sutures in a porcine model for fascial
Falk Birkenfeld et al.
The Journal of craniofacial surgery, 23(4), 953-956 (2012-07-11)
The objectives of this study were (i) to evaluate different fracture mechanisms for orbital floor fractures and (ii) to measure forces and displacement of intraorbital tissue after orbital traumata to predict the necessity of strength for reconstruction materials. Six fresh

Articles

Innovations in polymer technology have had a significant impact on the advancement of novel drug delivery systems.

AliAliphatic polyesters, including polylactide and polyglycolide, are biodegradable polymers widely used in medical applications.

Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.

Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service